Target Group Inc (CBDY)
0.0045
0.00 (0.00%)
USD |
OTCM |
Apr 22, 16:00
Target Group Cash from Investing (TTM): 0.4169M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.4169M |
September 30, 2023 | 0.2099M |
June 30, 2023 | 0.2705M |
March 31, 2023 | 0.6145M |
December 31, 2022 | 1.015M |
September 30, 2022 | 0.7576M |
June 30, 2022 | 0.6019M |
March 31, 2022 | -0.7587M |
December 31, 2021 | -1.406M |
September 30, 2021 | -1.287M |
June 30, 2021 | -1.560M |
March 31, 2021 | -1.762M |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | -3.800M |
September 30, 2019 | -5.136M |
June 30, 2019 | -6.053M |
Date | Value |
---|---|
March 31, 2019 | -3.791M |
December 31, 2018 | -1.804M |
September 30, 2018 | -0.3029M |
June 30, 2018 | 0.00 |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-6.053M
Minimum
Jun 2019
1.015M
Maximum
Dec 2022
-1.192M
Average
-0.7587M
Median
Mar 2022
Cash from Investing (TTM) Benchmarks
Acasti Pharma Inc | -1.452M |
Aurinia Pharmaceuticals Inc | -6.706M |
Edesa Biotech Inc | 0.00 |
Lexaria Bioscience Corp | -0.1991M |
Xenon Pharmaceuticals Inc | -117.17M |